Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2008
Because well-designed, randomized, controlled clinical trials are lacking in patients with advanced gastric cancer (AGC), and because randomly allocating patients to treatments that do not accord with their preferences may influence trial validity, the investigators employed a patient preference randomized trial design to compare the efficacy of second-line chemotherapy and best supportive care.
Epistemonikos ID: f959b1165366811c397c0a93272073646de31153
First added on: May 05, 2024